Cargando…

Interruption of Infection Transmission in the Onchocerciasis Focus of Ecuador Leading to the Cessation of Ivermectin Distribution

Introduction: A clinically significant endemic focus of onchocerciasis existing in Esmeraldas Province, coastal Ecuador has been under an ivermectin mass drug administration program since 1991. The main transmitting vector in this area is the voracious blackfly, Simulium exiguum. This paper describe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovato, Raquel, Guevara, Angel, Guderian, Ronald, Proaño, Roberto, Unnasch, Thomas, Criollo, Hipatia, Hassan, Hassan K., Mackenzie, Charles D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031166/ https://www.ncbi.nlm.nih.gov/pubmed/24853587 http://dx.doi.org/10.1371/journal.pntd.0002821

Ejemplares similares

Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
por: Guevara, Ángel, et al.
Publicado: (2018)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
por: Vieira, Juan Carlos, et al.
Publicado: (2007)

The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa
por: Katabarwa, Moses N., et al.
Publicado: (2020)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador
por: Anselmi, Mariella, et al.
Publicado: (2015)

Transmission of Onchocerciasis in Wadelai Focus of Northwestern Uganda Has Been Interrupted and the Disease Eliminated
por: Katabarwa, Moses N., et al.
Publicado: (2012)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
por: Katabarwa, Moses N., et al.
Publicado: (2013)

First description of Trypanosoma cruzi human infection in Esmeraldas province, Ecuador
por: Guevara, Ángel, et al.
Publicado: (2014)

The Imaramagambo Onchocerciasis Focus in Southwestern Uganda: Interruption of Transmission after Disappearance of the Vector Simulium neavei and Its Associated Freshwater Crabs
por: Katabarwa, Moses N., et al.
Publicado: (2016)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus
por: Botto, Carlos, et al.
Publicado: (2016)

Interruption of Transmission of Onchocerca volvulus in the Southern Chiapas Focus, México
por: Rodríguez-Pérez, Mario A., et al.
Publicado: (2013)

The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria
por: Richards, Frank O., et al.
Publicado: (2020)

Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
por: Mackenzie, Charles D, et al.
Publicado: (2003)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Diagnostics for onchocerciasis in the era of elimination
por: Unnasch, Thomas R, et al.
Publicado: (2018)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2017)

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa
por: Borsboom, Gerard JJM, et al.
Publicado: (2003)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon
por: Kouam, Marc K, et al.
Publicado: (2013)

Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study
por: Banla, Méba, et al.
Publicado: (2014)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
por: Noma, Mounkaila, et al.
Publicado: (2014)

Post-elimination surveillance in formerly onchocerciasis endemic focus in Southern Mexico
por: Fernández-Santos, Nadia A., et al.
Publicado: (2020)

Two Nigerian States (Plateau and Nasarawa) Have Eliminated Transmission of Human Onchocerciasis—A Report of Post-Ivermectin Mass Drug Administration Surveillance
por: Miri, Emmanuel S., et al.
Publicado: (2023)

Yaws elimination in Ecuador: Findings of a serological survey of children in Esmeraldas province to evaluate interruption of transmission
por: Cooper, Philip J., et al.
Publicado: (2022)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
por: Amuyunzu-Nyamongo, Mary, et al.
Publicado: (2011)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon
por: Abong, Raphael Awah, et al.
Publicado: (2021)

Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis
por: Abanobi, Okwuoma, et al.
Publicado: (2011)

Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Elimination of Onchocerciasis from Mexico
por: Rodríguez-Pérez, Mario A., et al.
Publicado: (2015)

Outcome of Ivermectin in Cancer Treatment: An Experience in Loja-Ecuador
por: Jiménez-Gaona, Yuliana, et al.
Publicado: (2023)

The interruption of transmission of onchocerciasis in Kaduna, Kebbi and Zamfara states, Nigeria: another milestone achievement
por: Isiyaku, Sunday, et al.
Publicado: (2022)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Elimination of Simulium neavei–Transmitted Onchocerciasis in Wambabya–Rwamarongo Focus of Western Uganda
por: Katabarwa, Moses N., et al.
Publicado: (2020)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity
por: Richards, FO, et al.
Publicado: (2005)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
por: Forrer, Armelle, et al.
Publicado: (2021)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
por: Yirga, Daniel, et al.
Publicado: (2010)

Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia
por: Samuel, Abdi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a6nshbth0mtrmth5udugr2bv03